ONX‐0914 inhibits LMP7 (ß5i) and LMP2 (ß1i) sites of the immunoproteasome, and LU‐102 inhibits proteasome ß2 sites in ALL. This evidence concerns the gene PSMB8 and acute lymphoblastic leukemia.